Literature DB >> 23250564

[Rivarobaxan for patients with recent acute coronary syndrome : ATLAS ACS 2-TIMI 51].

N Frey1, S Nitschmann.   

Abstract

Entities:  

Year:  2013        PMID： 23250564     DOI： 10.1007/s00108-012-3205-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  2 in total

1.  A new era in secondary prevention after acute coronary syndrome.

Authors:  Matthew T Roe; E Magnus Ohman
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Apixaban with antiplatelet therapy after acute coronary syndrome.

Authors:  John H Alexander; Renato D Lopes; Stefan James; Rakhi Kilaru; Yaohua He; Puneet Mohan; Deepak L Bhatt; Shaun Goodman; Freek W Verheugt; Marcus Flather; Kurt Huber; Danny Liaw; Steen E Husted; Jose Lopez-Sendon; Raffaele De Caterina; Petr Jansky; Harald Darius; Dragos Vinereanu; Jan H Cornel; Frank Cools; Dan Atar; Jose Luis Leiva-Pons; Matyas Keltai; Hisao Ogawa; Prem Pais; Alexander Parkhomenko; Witold Ruzyllo; Rafael Diaz; Harvey White; Mikhail Ruda; Margarida Geraldes; Jack Lawrence; Robert A Harrington; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-07-24       Impact factor: 91.245
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.